Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Clears Merck's Gardasil To Ease HPV Vaccine Shortage; AstraZeneca, Astellas Also Gain Approvals

This article was originally published in PharmAsia News

Executive Summary

July kicks off a good start for the Japanese subsidiary of Merck & Co. Inc., known as Merck, Sharp & Dohme, with three new drug approvals from Japan's Ministry of Health, Labor and Welfare. Among them, cervical cancer vaccine Gardasil will largely benefit from a recently expanded Japanese government public coverage program for human papillomavirus vaccines

You may also be interested in...



Emerging Views On Emerging Markets: Bank of America Merrill Lynch Global Healthcare Conference

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the recent Morgan Stanley Global Healthcare Conference in New York ('Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference,' PharmAsia News, Sept. 22, 2011). For this profile, we zoom in on the Bank of America Merrill Lynch Global Healthcare Conference, held Sept. 15-16 in London.

Emerging Views On Emerging Markets: Bank of America Merrill Lynch Global Healthcare Conference

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the recent Morgan Stanley Global Healthcare Conference in New York ('Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference,' PharmAsia News, Sept. 22, 2011). For this profile, we zoom in on the Bank of America Merrill Lynch Global Healthcare Conference, held Sept. 15-16 in London.

AstraZeneca's Nexium, J&J's Simponi Lead Charge Of New Products To Receive Reimbursement Prices In Japan

TOKYO - A new round of drugs were cleared for market launch in Japan after the latest round of National Health Insurance price listings, and AstraZeneca PLC's blockbuster Nexium (esomeprazole), waning in the West but picking up speed in Asian markets, leads the new wave of products

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC078449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel